Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease

Taylor R. Jay, Anna M. Hirsch, Margaret L. Broihier, Crystal M. Miller, Lee E. Neilson, Richard M. Ransohoff, Bruce Lamb, Gary E. Landreth

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Neuroinflammation is an important contributor to Alzheimer's disease (AD) pathogenesis, as underscored by the recent identification of immune-related genetic risk factors for AD, including coding variants in the gene TREM2 (triggering receptor expressed on myeloid cells 2). Understanding TREM2 function promises to provide important insights into how neuroinflammation contributes to AD pathology. However, studies so far have produced seemingly conflicting results, with reports that amyloid pathology can be both decreased and increased in TREM2-deficientADmouse models. In this study, we unify these previous findings by demonstrating thatTREM2deficiency ameliorates amyloid pathology early, but exacerbates it late in disease progression in the APPPS1–21 mouse model of AD. We also demonstrate that TREM2 deficiency decreases plaque-associated myeloid cell accumulation by reducing cell proliferation, specifically late in pathology. In addition, TREM2 deficiency reduces myeloid cell internalization of amyloid throughout pathology, but decreases inflammation-related gene transcript levels selectively late in disease progression. Together, these results suggest that TREM2 plays distinct functional roles at different stages in AD pathology.

Original languageEnglish (US)
Pages (from-to)637-647
Number of pages11
JournalJournal of Neuroscience
Volume37
Issue number3
DOIs
StatePublished - Jan 18 2017

Fingerprint

Myeloid Cells
Disease Progression
Alzheimer Disease
Pathology
Amyloid
Genes
Cell Proliferation
Inflammation

Keywords

  • AD
  • Genetic risk factor
  • Inflammation
  • Microglia
  • Myeloid cell
  • Neuroinflammation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., ... Landreth, G. E. (2017). Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. Journal of Neuroscience, 37(3), 637-647. https://doi.org/10.1523/JNEUROSCI.2110-16.2017

Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. / Jay, Taylor R.; Hirsch, Anna M.; Broihier, Margaret L.; Miller, Crystal M.; Neilson, Lee E.; Ransohoff, Richard M.; Lamb, Bruce; Landreth, Gary E.

In: Journal of Neuroscience, Vol. 37, No. 3, 18.01.2017, p. 637-647.

Research output: Contribution to journalArticle

Jay, TR, Hirsch, AM, Broihier, ML, Miller, CM, Neilson, LE, Ransohoff, RM, Lamb, B & Landreth, GE 2017, 'Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease', Journal of Neuroscience, vol. 37, no. 3, pp. 637-647. https://doi.org/10.1523/JNEUROSCI.2110-16.2017
Jay, Taylor R. ; Hirsch, Anna M. ; Broihier, Margaret L. ; Miller, Crystal M. ; Neilson, Lee E. ; Ransohoff, Richard M. ; Lamb, Bruce ; Landreth, Gary E. / Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 3. pp. 637-647.
@article{f0c7e2bc1e4c48c99bf036e3a449f7fa,
title = "Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease",
abstract = "Neuroinflammation is an important contributor to Alzheimer's disease (AD) pathogenesis, as underscored by the recent identification of immune-related genetic risk factors for AD, including coding variants in the gene TREM2 (triggering receptor expressed on myeloid cells 2). Understanding TREM2 function promises to provide important insights into how neuroinflammation contributes to AD pathology. However, studies so far have produced seemingly conflicting results, with reports that amyloid pathology can be both decreased and increased in TREM2-deficientADmouse models. In this study, we unify these previous findings by demonstrating thatTREM2deficiency ameliorates amyloid pathology early, but exacerbates it late in disease progression in the APPPS1–21 mouse model of AD. We also demonstrate that TREM2 deficiency decreases plaque-associated myeloid cell accumulation by reducing cell proliferation, specifically late in pathology. In addition, TREM2 deficiency reduces myeloid cell internalization of amyloid throughout pathology, but decreases inflammation-related gene transcript levels selectively late in disease progression. Together, these results suggest that TREM2 plays distinct functional roles at different stages in AD pathology.",
keywords = "AD, Genetic risk factor, Inflammation, Microglia, Myeloid cell, Neuroinflammation",
author = "Jay, {Taylor R.} and Hirsch, {Anna M.} and Broihier, {Margaret L.} and Miller, {Crystal M.} and Neilson, {Lee E.} and Ransohoff, {Richard M.} and Bruce Lamb and Landreth, {Gary E.}",
year = "2017",
month = "1",
day = "18",
doi = "10.1523/JNEUROSCI.2110-16.2017",
language = "English (US)",
volume = "37",
pages = "637--647",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "3",

}

TY - JOUR

T1 - Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease

AU - Jay, Taylor R.

AU - Hirsch, Anna M.

AU - Broihier, Margaret L.

AU - Miller, Crystal M.

AU - Neilson, Lee E.

AU - Ransohoff, Richard M.

AU - Lamb, Bruce

AU - Landreth, Gary E.

PY - 2017/1/18

Y1 - 2017/1/18

N2 - Neuroinflammation is an important contributor to Alzheimer's disease (AD) pathogenesis, as underscored by the recent identification of immune-related genetic risk factors for AD, including coding variants in the gene TREM2 (triggering receptor expressed on myeloid cells 2). Understanding TREM2 function promises to provide important insights into how neuroinflammation contributes to AD pathology. However, studies so far have produced seemingly conflicting results, with reports that amyloid pathology can be both decreased and increased in TREM2-deficientADmouse models. In this study, we unify these previous findings by demonstrating thatTREM2deficiency ameliorates amyloid pathology early, but exacerbates it late in disease progression in the APPPS1–21 mouse model of AD. We also demonstrate that TREM2 deficiency decreases plaque-associated myeloid cell accumulation by reducing cell proliferation, specifically late in pathology. In addition, TREM2 deficiency reduces myeloid cell internalization of amyloid throughout pathology, but decreases inflammation-related gene transcript levels selectively late in disease progression. Together, these results suggest that TREM2 plays distinct functional roles at different stages in AD pathology.

AB - Neuroinflammation is an important contributor to Alzheimer's disease (AD) pathogenesis, as underscored by the recent identification of immune-related genetic risk factors for AD, including coding variants in the gene TREM2 (triggering receptor expressed on myeloid cells 2). Understanding TREM2 function promises to provide important insights into how neuroinflammation contributes to AD pathology. However, studies so far have produced seemingly conflicting results, with reports that amyloid pathology can be both decreased and increased in TREM2-deficientADmouse models. In this study, we unify these previous findings by demonstrating thatTREM2deficiency ameliorates amyloid pathology early, but exacerbates it late in disease progression in the APPPS1–21 mouse model of AD. We also demonstrate that TREM2 deficiency decreases plaque-associated myeloid cell accumulation by reducing cell proliferation, specifically late in pathology. In addition, TREM2 deficiency reduces myeloid cell internalization of amyloid throughout pathology, but decreases inflammation-related gene transcript levels selectively late in disease progression. Together, these results suggest that TREM2 plays distinct functional roles at different stages in AD pathology.

KW - AD

KW - Genetic risk factor

KW - Inflammation

KW - Microglia

KW - Myeloid cell

KW - Neuroinflammation

UR - http://www.scopus.com/inward/record.url?scp=85010369316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010369316&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2110-16.2017

DO - 10.1523/JNEUROSCI.2110-16.2017

M3 - Article

C2 - 28100745

AN - SCOPUS:85010369316

VL - 37

SP - 637

EP - 647

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 3

ER -